CapsoVision, Inc (CV): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
CapsoVision, Inc (CV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 cv-20260702xex1001.htm EX-10.1 Document Exhibit 10.01 Certain confidential information contained in this document, marked by [* * *], has been omitted pursuant to Item 601 (b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information
How this was made
The 30-second read
Why it matters
Based on the excerpt, the newest concrete item is the amended and restated consulting agreement effective July 2, 2026; however, the compensation specifics are redacted in Exhibit 10.1.
Market read
This is a routine governance/compensation disclosure with limited disclosed economics in the provided text, so it is unlikely to drive a major repricing without the redacted terms.
What to watch
Traders should verify whether the consulting arrangement implies ongoing R&D/product work, and whether any director/officer departure or election details are included elsewhere in the full 8-K beyond the excerpt.
Background
The SEC filing is a Form 8-K under Item 5.02, covering departures/elections/appointments and compensatory arrangements for certain officers/directors.
Ticker impact
CapsoVision filed an 8-K disclosing an amended and restated consulting agreement with Joanne C Imperial, effective July 2, 2026.
Low near-term impact; any move would likely be muted unless the omitted exhibit contains material compensation terms.
Form 8-K Item 5.02 indicates a compensatory arrangement, but the provided text omits the key economic terms (Exhibit 10.1 redactions), reducing tradable specificity.
Market effects
No clear sector read-through; this appears company-specific HR/contract documentation.
None indicated.
None indicated.
Counterpoint
If the omitted Exhibit 10.1 includes unusually large compensation or a role change, the market reaction could be larger than the excerpt suggests.
Key entities
- companyCapsoVision, Inc.
Delaware corporation filing the 8-K disclosing a compensatory consulting arrangement.
- personJoanne C Imperial MD
Named consultant in the amended and restated consulting agreement effective July 2, 2026.
